Algo version: 0.98b
Dynavax Technologies is listed at the OTC Exchange
Dynavax Technologies [DVAXW]
OTC Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Dynavax Technologies stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Dynavax Technologies 10 years ago, but if you had invested on Friday 7th of January 2022 when the price was $8.09, you would have made a loss of $-0.590 per share or -7.29%

We do not have enough data to give you this answer.

Dynavax Technologies has N/A of the business financed by loans. This puts the company at N/A risk in periods of high inflation where borrowing costs usually go up. With a N/A cash flow to debt ratio of 0, the company's ability to pay off the debt is N/A. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Dynavax Technologies to be low [0 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.